9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994) / Menis, J., Bironzo, P., Radj, G., Greillier, L., Monnet, I., Livi, L., Young, R., Decroisette, C., Cloarec, N., Robinet, G., Schott, R., Califano, R., De Marinis, F., Mauer, M., Pochesci, A., Silva, M., Caramella, C., Dingemans, A-M., Dive, C., Besse, B.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 31:(2020), p. S1420. [10.1016/j.annonc.2020.10.494]
9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)
Silva, M.Membro del Collaboration Group
;
2020-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
